Genmab, an international biotechnology company specialising in the creation and development of differentiated antibody therapeutics for the treatment of cancer, has adopted the Genedata Biopharma Platform to support their global oncology programs.
The Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) recently announced it had been awarded federal funding for a new building which will provide a new research centre to investigate how interactions among microbes, water, soil, and plants shape entire ecosystems
Integrated DNA Technologies (IDT) has announced that it is teaming up with 3CR Bioscience (3CR) to widen access to quality custom solutions for genotyping screening
IDBS’ E-WorkBook has been implemented by Solvay, an advanced materials and speciality chemicals company, as part of a digital transformation project that has removed paper-based processes across the organisation
Integrated DNA Technologies (IDT) has announced an expansion to its next generation sequencing (NGS portfolio) with the launch of Custom NGS Adapters that are designed to provide an easy and flexible customised adapter solution directly to scientists
BioCity, a life science incubator and business collective, has announced investment in INCUS Performance. Founded in 2016, INCUS Performance is a sports technology start-up that is helping athletes to train better using data
Integrated DNA Technologies (IDT) has announced that it is once again partnering with the International Genetically Engineered Machine (iGEM) Foundation to support young researchers and promote scientific progress.
The American College of Radiology (ACR) Data Science Institute (DSI) has launched its ACR AI-LAB software platform securing GE Healthcare as a key collaborator
The latest release of Matereality Version 12 software can be used in conjunction with eLim, a new bolt-on for companies to manage and operate their test labs
ACD/Labs has announced the launch of a new web-based application in support of high throughput (HT) experimentation. Katalyst D2D offers a single interface for high throughput experimentation and parallel synthesis
As not only the HPC industry but the larger computing ecosystem tries to overcome the slowdown and eventual end of transistor scaling described by Moore’s Law, scientists and researchers are implementing programmes that will define the technologies and new materials needed to supplement, or repla
Architectural specialisation is one option to continue to improve performance beyond the limits imposed by the slow down in Moore’s Law.
As the complexity of both HPC hardware and the challenges that scientists are trying to solve using HPC systems increases, ensuring a system is utilised efficiently is necessary to deliver a computing service with value for money and a high research output.
With data rates increasing and more complex challenges arising in life sciences, Panasas’ Jim Donovan and Dale Brantly discuss the benefits of using HPC for these workloads
